A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

July 12, 2025

Study Completion Date

July 12, 2025

Conditions
Healthy Participants
Interventions
DRUG

balcinrenone/ dapagliflozin

Participants will be receiving balcinrenone/ dapagliflozine in fasted or fed condition.

DRUG

quinidine

Participants will be receiving quinidine orally in fasted condition.

Trial Locations (1)

HA1 3UJ

Research Site, Harrow

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY